chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pericarditis; Heart surgery; Experienced shortness of breath which turned out to be fluid around the lining of her heart/I was almost died and it was hard for me to breath; Experienced shortness of breath which turned out to be fluid around the lining of her heart/fluid around her heart which was pericarditis and did have heart surgery; I did get extreme pain and fever; I did get extreme pain and fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 65-year-old female patient received BNT162b2 (BNT162B2), on 10Apr2022 as dose 3 (booster), single (Lot number: 33025BD) at the age of 65 years for covid-19 immunisation. The patient's relevant medical history included: "Blood pressure high" (unspecified if ongoing). Concomitant medication(s) included: AMLODIPINE taken for hypertension. Vaccination history included: pfizer coviD-19 vaccine (Dose: 02, Lot no.: ER8733), administration date: 29Mar2021, when the patient was 64-year-old, for COVID-19 immunization; pfizer coviD-19 vaccine (Dose: 01, Lot no.: EN6205), administration date: 04Mar2021, when the patient was 64-year-old, for COVID-19 immunization. The following information was reported: PERICARDITIS (medically significant), outcome "unknown"; CARDIAC OPERATION (medically significant), outcome "unknown", described as "Heart surgery"; DYSPNOEA (non-serious), outcome "unknown", described as "Experienced shortness of breath which turned out to be fluid around the lining of her heart/I was almost died and it was hard for me to breath"; PLEURAL EFFUSION (non-serious), outcome "unknown", described as "Experienced shortness of breath which turned out to be fluid around the lining of her heart/fluid around her heart which was pericarditis and did have heart surgery"; PYREXIA (non-serious), PAIN (non-serious), outcome "unknown" and all described as "I did get extreme pain and fever". The events "pericarditis", "experienced shortness of breath which turned out to be fluid around the lining of her heart/i was almost died and it was hard for me to breath" and "experienced shortness of breath which turned out to be fluid around the lining of her heart/fluid around her heart which was pericarditis and did have heart surgery" required emergency room visit. Therapeutic measures were taken as a result of pericarditis, cardiac operation, dyspnoea.  Clinical course: The patient reported that when she took the vaccine she did get extreme pain and fever and then after some time she felt shortness of breath, and pericarditis. She do not know what was wrong with her when she was having shortness of breath she went to the hospital and they keep telling her they do not know. They gave her asthma medicine and then she went to emergency in the month of January. She was almost died and then they did test and said there was fluid in her heart that was pericarditis. She did not know what was wrong. What she knew she was having shortness of breath and it was hard for her to breath.
Patient received their booster dose too early. Previous doses were 5/10/21 and 7/8/21.
Thought to have broken a needle but after sending child with parent to ER for x-ray, found out needle/syringe was of retractable type.
PATIENT REPORTED LABORED BREATHING, LIGHT-HEADEDNESS, ANXIOUSNESS...ALMOST LIKE AN ANXIETY ATTACK THAT STARTED 10-15 MINS AFTER VACCINE ADMINISTRATION AND LASTED FOR ABOUT 15-20 MINS. PARAMEDICS ARRIVED AND TOOK PATIENT'S BLOOD PRESSURE, PULSE & OXYGENATION LEVEL - THEN ESCORTED PATIENT TO ER WHERE AN EKG WAS PERFORMED (IT WAS NORMAL) DOCTORS WHO EXAMINED PATIENT IN ER COULD FIND NOTHING WRONG. NEXT DAY PATIENT FEELS WELL.
Fever; body aches; headache; This is a spontaneous report from a non-contactable consumer or other non hcp.   A 24-years-old non-pregnant female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EL3247; Expiration Date: unknown), dose 2 via an unspecified route of administration on an unspecified date as 2nd dose, single for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 09Feb2021, the patient experienced fever, body aches, headache. The clinical outcome of the events was recovered.   No follow-up attempts are possible. No further information is expected.
Recurring hives beginning 9 (12/24/2021) days post vaccine and lasting to the present day 1/3/2022) still occurring). Raised hives that come and go throughout the day occurring on all areas of the body. Hives are extremely itchy. Intermittent burning/itchy sensation in the palms.
7/25/09 patient came in with 4 x 5 inch area of erythema surrounding injection site.  On 7/26/09 patient returned 5 x 5 inch, dr. diagnosed cellulitis
Coughing, post-nasal drip, itchy watery eyes, body aches, dizzy, headache, swollen glands (throat), sore throat.
Initial report received on 23 August 2007 from a physician in the United States. A patient (demographics not provided) had received a dose of Adacel date received, lot number, route and site not provided) and developed rheumatoid arthritis of "similar symptoms" after receiving Adacel. At the time of this report, the reporting physician was not completely convinced the "rheumatic symptoms" were directly associated with the vaccination of Adacel and requested further information from the manufacturer. No additional information was provided. Recovery status of the patient was not reported.
7 Aug 2004 patient was treated for Erythema Nodosum.  This condition manifested 6 days after immunization with Anthrax Vaccine.  Per patient this was the second episode, but was unable to correlate for episode with anthrax immunization prior to. Submitting this report per patients request.
RADIATING PAIN IN THE GROIN AREA TO HIS HIP AND UPWARDS.; CHILLS; SORE ARM OF INJECTION; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the patient experienced chills. On MAR-2021, the patient experienced sore arm of injection. On 25-APR-2021, the patient experienced radiating pain in the groin area to his hip and upwards. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from radiating pain in the groin area to his hip and upwards. On 09-MAY-2021, and chills, and sore arm of injection. This report was non-serious.
The rabies vaccine was administered on 3/28/00. The pt complained that 4 hours post vax she developed a headache, began vomiting, experienced joint pain in the arms and hands which lasted 24 hours. She reported these to her PMD.
FEELING COLD; BODY ACHES; FEVER ABOVE 100 F; This spontaneous report received from a consumer concerned a 27 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no medical history and no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: 21-JUN-2021) dose was not reported, administered on 07-APR-2021 to Right Arm for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced feeling cold. On 07-APR-2021, the subject experienced body aches. On 07-APR-2021, the subject experienced fever above 100 f. Laboratory data included: Body temperature (NR: not provided) above 100 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever above 100 f, feeling cold, and body aches. This report was non-serious.
Pfizer vaccine was administered outside of facility- reported by patient- ? NO LOT NUMBER WERE SUPPLIED -------------------------------------------------------------------------------------------------------- ACUTE PULMONARY EMBOLISM 2/13/2022 PLEURAL EFFUSION ACUTE RESPIRATORY FAILURE 1/11/2022 PLEURAL EFFUSION ACUTE PULMONARY EMBOLISM 2/13/2022 HEPATOCELLULAR CARCINOMA ACUTE RESPIRATORY FAILURE 1/11/2022 HEPATOCELLULAR CARCINOMA ACUTE PULMONARY EMBOLISM 2/13/2022 AV BLOCK, COMPLETE ACUTE RESPIRATORY FAILURE 1/11/2022 AV BLOCK, COMPLETE
Pt vaccinated with Influenza Vaccine development of Guillain Barre Synd had influenza vaccine on 21AUG90.
Started severe  belly pain  and went to Emergency room and diagnosed with mesenteric  vein thrombosis after the CT scan of the abdomen, treated with heparin drip, antibiotic and discharged with anticoagulant pills(Eliquis).  I am not sure that it is because of the vaccine my doctors are also not sure about it, but I am sure that I am a healthy person without any health issues . I am working as registered nurse, our unit is for covid-19 patient's since march 2020 and I had covid -19 on August month and recovered  after 3 weeks.
redness in the arm that spread after one day to the whole body and remained for more than a week as per patient,   sensitive to the touch.
This spontaneous report as received from a female consumer of unknown age reporting on herself. The patient was vaccinated with a dose of hepatitis B vaccine (recombinant) (manufacturer unknown) (dose, route and lot # not reported). No other co-suspects were reported. No concomitant medications were reported. On an unknown date, many years ago the patient developed 103 degrees fever after receiving Hepatitis B vaccines. No treatment information was reported. It was unknown if the patient sought medical attention. The outcome of the event was unknown. The relationship between the event and Hepatitis B vaccine (manufacturer unknown) was not reported. Additional information has been requested.
Patient stated that she after she received her injection, she developed a sharp pain in the L side of her chest.  EMS personnel was on site and ECG was performed and found to normal sinus rhythm.  Vital signs were as follows:  132/91, Pulse rate-64, Oxygen saturation was 94%.  Patient stated that she felt better after about 5-10 minutes.  Patient was able to go home.
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20a) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 05-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). On 05-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This is a case of product exposure during pregnancy with no associated AEs for this 31-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 31-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
This spontaneous report as received from a Registered Nurse concerning a 7 month old patient who on 12-NOV-2013 was vaccinated with an expired dose of ROTATEQ lot # 0579AE, exp date reported 27-OCT-2013, oral (dose not provided). No adverse effect was observed. This is one of several reports received from the same source. Additional information has been requested.
redness, induration, heat onset w/in 5' of IPV inj;extended to 5-6cm then abated p/application of ice;
Pt received Anthrax vaccination on 16OCT2018 and 04DEC2018 and Smallpox vaccination on 04DEC2018. Pt did not believe that she was pregnant at either of those visits. At that time it was discussed to avoid becoming pregnant for at least the next four weeks due to potential harm to unborn child. Pt realized on 15DEC that she had not had her menstrual cycle yet that month which usually occurs on 10DEC. Pt took a home pregnancy test on 15DEC which was positive but waited to discuss pregnancy with providers until 08JAN due to work related commitments. She had her initial OB/GYN visit on 14JAN where she was estimated to be at around 8 weeks gestational age and has a 10 week visit on 30JAN. Unit physician met with pt on 14JAN to discuss potential complications or outcomes of becoming pregnant after receiving Smallpox vaccination. Handout from website on the subject of pregnancy after smallpox vaccination was given to and reviewed with the pt. Pt self registered with the registry on 14JAN.
Initially following the first vaccine, I suffered from a high fever of 103.4 I took Tylenol and slept it off 12 hours. Since the first does I have felt lethargic and after the second dose I got a headache that I also just slept off.  However, mid June I started to have heart palpitations, my joints started stiffening up, and I was having lots of fatigue.  By mid July, I was sleeping more than I was awake.   My doctor put me on prednisone for a potential flare up and it worked until I tapered down. I am still experiencing cramping, muscle fatigue, body aches, and lethargy.   My headaches are constant and seeming to never go away. Tylenol helps a little but never completely resolved the symptoms.   In addition, since late July I have become extremely photosensitive. The sun makes me sick and flares my body up like nothing else.
Chest kinda hearting when tries to breath; Had the same symptoms but worst; Flu like symptoms; Terminating back pain; Feels the arm like if it's dragging it; Shivering in the inside; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest kind of hurting when tries to breath), CONDITION AGGRAVATED (Had the same symptoms but worst), INFLUENZA LIKE ILLNESS (Flu like symptoms), BACK PAIN (Terminating back pain) and MOBILITY DECREASED (Feels the arm like if it's dragging it) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced CHEST PAIN (Chest kinda hearting when tries to breath), CONDITION AGGRAVATED (Had the same symptoms but worst), INFLUENZA LIKE ILLNESS (Flu like symptoms), BACK PAIN (Terminating back pain), MOBILITY DECREASED (Feels the arm like if it's dragging it) and CHILLS (Shivering in the inside). At the time of the report, CHEST PAIN (Chest kinda hearting when tries to breath), CONDITION AGGRAVATED (Had the same symptoms but worst), INFLUENZA LIKE ILLNESS (Flu like symptoms), BACK PAIN (Terminating back pain), MOBILITY DECREASED (Feels the arm like if it's dragging it) and CHILLS (Shivering in the inside) outcome was unknown.            No concomitant medications were provided. No treatment medications were reported.   This case was linked to MOD-2021-361221 (Patient Link).
fever 103 in spite of APAP w/lt leg mild swelling & non use; vax given 1010 fever late PM/evening & into noc; t103 still @ 0500 AM; down to 99 w/APAP @ 1400 10JAN95;
Patient received SHINGRIX vaccine on Wednesday, 5/16 and soon thereafter developed mild fevers on and off, pain in right upper arm at the injection site and a red "rash" over the area. Notes area is itchy and painful to the touch. Has not taken an medications or applied anything topically. Area was worsening for a few days but now staying the same. 5/21/18 seen in office w/ NP: Injection site reaction, initial encounter. Advised warm compresses and diphenhydramine 25 mg q 6 hours. Follow-up visit scheduled with NP on Wednesday to ensure improvement/resolution. BENADRYL allergy 25mg Cap; Take 1 Cap by mouth every 6 hours as needed Dispense: 30 Cap; Refill: 0. Seen 5/23/18 for f/u: Area much improved.
double vision / diagnosed with sixth nerve palsy; hearing loss / diagnosed with sensorineural hearing loss; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 27-FEB-2017, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route of administration not specified) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unspecified date, reported as shortly after receiving zoster vaccine live (ZOSTAVAX), the patient suffered double vision and was diagnosed with sixth nerve palsy and also suffered hearing loss and was diagnosed with sensorineural hearing loss. As a result of the zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries, suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The patient had not recovered from the events. The reporter considered sixth nerve palsy and sensorineural hearing loss to be related to Zoster Vaccine Live (ZOSTAVAX).     Upon internal review, sixth nerve palsy and sensorineural hearing loss were determined to be medically significant and to be disabling.
Information has been received from a consumer concerning her 6 year old grandson with no reported medical history who in 1998 was vaccinated with MMR II, SC. There were no concomitant medications. Subsequently, the pt developed autism. The pt sought unspecified medical attention. Autism was considered to be disabling. Additional info has been requested.
The next day after receiving my vaccination, I started having vaginal bleeding. However 2 weeks prior to my vaccination I already had my menstrual cycle. I typically either spot or have a small period that lasts 3-4 days due to my birth control (implant). Today 4/26/21, I am still currently experiencing heavy vaginal bleeding, and I am not sure if I consider this my menstrual cycle. It is now more than 2 weeks and I am still bleeding.
within 12 hours of getting first dose began breaking out in hives all over, from scalp to toes. At first effects were able to be helped with bendryl. After 2 weeks became unable to help so called doctor, was perscribed a dose pack, and with the help of bendryl was able continue daily function. On the last day of dosepak started to break out heavily again and was put on prednizone while waiting for an appointment 3/15/22 with an allergist. on Friday March 11th I woke up with my left eye swollen shut and hives and swelling on lips, in  the inner mouth, left sife of face swollen, i thought was having issues breathing so went to hospital, where they gave me a shot of benadryl  and wrote a  script for zyrtec 2x day
This medically confirmed spontaneous report (initial receipt 28-OCT-2014) concerns a 44 year old male patient. On 26-OCT-2014, AFLURIA underwent temperature excursion at 50 degree Fahrenheit. On 27-OCT-2014, AFLURIA again had temperature excursion at 50 degree Fahrenheit for undetermined amount of time. On 27-OCT-2014, the patient received temperature excursion AFLURIA (batch number: T50507) via intramuscular route at 0.5 ml. Outcome was reported as unknown. Reporter's comments: The reporter assessed the event as non-serious.
Myalgia, NauseaVomiting, weakness Narrative:  Per nursing report: "2nd dose of COVID 19 vaccine on 2/1/21 @ 1030am complains of nausea, body aches and  weakness"
The pt experienced left arm swelling from elbow to deltoid, with pain, erythema, decreased strength in left arm. Pt had received dose 5 of Anthrax prior to symptoms.
No adverse effect; 10 month old patient received a third dose of ROTATEQ today; This spontaneous report was received from a nurse prescriber regarding a 10 month old patient.   The patient's medical history, concomitant medication, and drug reactions/allergies were not reported. On 09-OCT-2019, the patient was vaccinated with 3rd dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ)  (lot/batch#, expiration date unknown) inappropriate schedule of vaccine administered. No adverse effects were reported.
During the night before the inoculation, patient got severe pain in neck (opposite side of inoculation site upper (L) arm, pain on (R) neck went to see his PT doctor who said he'd had "several others experiencing" neck pain after this shot for shingles. Does not follow "nerve lines" - pain lasted 3 days.
This spontaneous case reported by a consumer, describes the occurrence of tinnitus in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced tinnitus. At the time of the report, tinnitus outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information reported. Upon follow-up regarding the event experienced, some other people had tinnitus, but not as bad. Most recent follow-up information incorporated: On Sep 7, 2021: Follow-up document contained no new information.
Headache, chills, soreness in legs, tired.  Starting the morning after the injection and lasting all day.
body aches; shivering; fever of 99.5F; This case was reported by a nurse via call center representative and described the occurrence of general body pain in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On 4th March 2020, the patient received the 2nd dose of Shingrix and Boostrix. In March 2020, less than a week after receiving Shingrix and Boostrix, the patient experienced general body pain, shivering and fever. On an unknown date, the outcome of the general body pain, shivering and fever were not recovered/not resolved.   It was unknown if the reporter considered the general body pain, shivering and fever to be related to Shingrix and Boostrix.  Additional details were provided as follows: The patient had experienced body aches, shivering, and a fever temperature of 99.5F. The events were ongoing at the time of this report. The patient mentioned her concern about the symptoms and concerned with the Corona virus. The patient did not have the lot/exp of either vaccine.